watch

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

Pipeline - Changing Possibilities in Hemophilia (CPiH) Innovation

he Pipeline video in the CPiH Innovation video series. © 2013 Novo Nordisk All rights reserved. 0513-00015950-1 July 2013

Novo Nordisk A/S video

Pipeline - Changing Possibilities in Hemophilia (CPiH) Innovation

Novo Nordisk A/S video

Celebrating 25 years of Novo Nordisk Insulin Pens

Novo Nordisk A/S video

The Novo Nordisk Way

Executives

Lars Rebien Sørensen, President and chief executive officer
Lars Rebien Sørensen joined Novo Nordisk’s Enzymes Marketing in 1982. Over the years, he has completed several overseas postings, including in the Middle East and the US. Mr Sørensen was appointed a member of Corporate Management in May 1994, and in December 1994 he was given special responsibility within Corporate Management for Health Care. He was appointed president and chief executive officer in November 2000.
Mr Sørensen is a member of the board of Danmarks Nationalbank, Denmark, Thermo Fisher Scientific Inc., US, as well as a member of the Supervisory Board of Bertelsmann AG, Germany.
Mr Sørensen has an MSc in Forestry from the Royal Veterinary and Agricultural University, Denmark (now the Faculty of Sciences of the University of Copenhagen) from 1981 and a BSc in International Economics from the Copenhagen Business School from 1983. Mr Sørensen received the French award Chevalier de l'Ordre National de la Légion d'Honneur in 2005. In October 2007, Mr Sørensen became an adjunct professor at the Faculty of Life Sciences of the University of Copenhagen.
Mr Sørensen is a Danish national, born on 10 October 1954.
Jesper Brandgaard, Executive vice president and chief financial officer
Jesper Brandgaard joined Novo Nordisk in 1999 as senior vice president of Corporate Finance and was appointed executive vice president and chief financial officer in November 2000. He serves as chairman of the boards of SimCorp A/S and NNIT A/S, both in Denmark.
Mr Brandgaard has an MSc in Economics and Auditing from 1990 as well as an MBA from 1995, both from the Copenhagen Business School, Denmark.
Mr Brandgaard is a Danish national, born on 12 October 1963.
Kåre Schultz, Executive vice president and chief operating officer
Kåre Schultz joined Novo Nordisk in 1989 as an economist in Health Care, Economy & Planning. In November 2000, he was appointed chief of staffs. In March 2002, he took over the position of executive vice president and chief operating officer. Mr Schultz is a member of the Board of LEGO A/S and chairman of the Board of Royal Unibrew A/S, both Denmark.
Mr Schultz has an MSc in Economics from the University of Copenhagen, Denmark, from 1987.
Mr Schultz is a Danish national, born on 21 May 1961.

News & Analysis

You may also be interested in: